Clinical Trials Directory

Trials / Completed

CompletedNCT05898113

Effect of the Intake of Corbella Extra Virgin Olive Oil on the Microbiota-gut-brain Axis in Healthy Adults (HEVOOC)

Development of Oil with Healthy Properties Based on Corbella Olive Variety (HEVOOC)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
University of Barcelona · Academic / Other
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

The consumption of the improved extra virgin olive oil (EVOO) of the Corbella variety could have a beneficial effect on the microbiota-intestine-brain axis (MGBA). Olive oil contains polyphenols that are not present in other oils, notably oleocanthal and oleacein, which behave similarly to ibuprofen and have a protective effect on some neurodegenerative diseases. The polyphenols of the oil present prebiotic characteristics, at the level of the intestinal microbiota, which metabolizes them forming bioactive metabolites that can have a modulating effect on the MGBA, improving brain health. In this study, the researchers seek to identify the benefits of the consumption of Corbella variety EVOO on MGBA in healthy participants. The overall benefit of the study would be to achieve knowledge that would allow its future applicability to prevent and improve certain diseases and in general contribute to optimal health.

Detailed description

To evaluate possible effects on MGBA, a randomized, controlled, crossover nutritional trial will be conducted. Thirty healthy adult participants (between 18 and 35 years of age, with 50% male and 50% female) will be included according to the estimated sample size. Participants will consume a daily amount of 0.7 g Corbella EVOO/kg body weight plus their normal diet (experimental intervention) and 0.7 g refined olive oil (ROO)/kg body weight plus their normal diet (control intervention) for 1 month. Biological samples (plasma, peripheral blood mononuclear cells, serum, 24-hour urine, feces and saliva) will be obtained at baseline and at the end of each trial arm.

Conditions

Interventions

TypeNameDescription
OTHEREXTRA VIRGIN OLIVE OILParticipants will consume a daily amount of extra virgin olive oil. Can consume the oil either raw or cooked
OTHEROLIVE OIL LOW POLYPHENOLParticipants will consume a daily amount of olive oil low polyphenol. Can consume the oil either raw or cooked

Timeline

Start date
2023-06-19
Primary completion
2023-08-10
Completion
2023-11-24
First posted
2023-06-12
Last updated
2025-04-01

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT05898113. Inclusion in this directory is not an endorsement.